Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT04609800
What this trial is testing

Study on the Utilization of Cabozantinib in Adult Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC) in 2nd Line Treatment Following Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Therapy Under Real-real Life Clinical Setting in France.

Who this might be right for
Renal Cell Carcinoma
Ipsen
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Large-scale testing (Phase 3)WithdrawnNCT00061178
What this trial is testing

Efficacy and Safety Study of rhuMAb VEGF to Treat Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer
Genentech, Inc.
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Early research (Phase 1)Study completedNCT02390843
What this trial is testing

Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors

Who this might be right for
RetinoblastomaClear Cell SarcomaRenal Cell Carcinoma+9 more
Emory University 13
Early research (Phase 1)Ended earlyNCT05397093
What this trial is testing

ITIL-306 in Advanced Solid Tumors

Who this might be right for
Epithelial Ovarian CancerNon-small Cell Lung CancerRenal Cell Carcinoma
Instil Bio 1
Not applicableNot Yet RecruitingNCT06585878
What this trial is testing

A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaRCCKidney Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Not applicableNot Yet RecruitingNCT07833085
What this trial is testing

CAIX-targeted PET/CT in Solid Tumors

Who this might be right for
Malignant Solid TumorsClear Cell Renal Cell CarcinomaLung Cancer (NSCLC)+1 more
Zhongnan Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT05641935
What this trial is testing

Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation

Who this might be right for
Recurrent Renal Cell CarcinomaRenal Cell Carcinoma
john eisenbrey 210
Not applicableStudy completedNCT02326558
What this trial is testing

Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
RenJi Hospital 183
Large-scale testing (Phase 3)Looking for participantsNCT06661720
What this trial is testing

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma (RCC)Stage II Renal Pelvis Cancer AJCC v8+1 more
Alliance for Clinical Trials in Oncology 1,040
Not applicableStudy completedNCT03776123
What this trial is testing

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

Who this might be right for
Renal Cell CarcinomaHepatocellular CarcinomaDifferentiated Thyroid Carcinoma
Ipsen 347
Testing effectiveness (Phase 2)Study completedNCT00726323
What this trial is testing

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 74
Not applicableStudy completedNCT03663946
What this trial is testing

Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Bristol-Myers Squibb 81
Testing effectiveness (Phase 2)WithdrawnNCT02232646
What this trial is testing

BBI503 in Adult Patients With Advanced Urologic Malignancies

Who this might be right for
Urologic MalignanciesRenal Cell CarcinomaUrothelial Carcinoma
Sumitomo Pharma America, Inc.
Testing effectiveness (Phase 2)WithdrawnNCT01834183
What this trial is testing

Tivozanib + Gemcitabine in Metastatic RCC

Who this might be right for
Renal Cell Carcinoma
Dana-Farber Cancer Institute
Early research (Phase 1)Study completedNCT04540705
What this trial is testing

Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 30
Large-scale testing (Phase 3)Study completedNCT00005966
What this trial is testing

Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003656
What this trial is testing

Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Weill Medical College of Cornell University 26
Not applicableStudy completedNCT01412671
What this trial is testing

Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program

Who this might be right for
Carcinoma, Renal Cell
Bayer 117
Next Page